Morgan Stanley has slightly increased the target price for SUNeVision Holdings (01686, Financial) by 9.5%, raising it from HK$4.2 to HK$4.6. The earnings forecast for the company remains unchanged, and the stock rating is maintained at "overweight."
The investment bank's base assumptions project that the MSR business of SUNeVision will grow 2% annually from 2024 to 2026. The mixed utilization rates for these years are expected to be 64.1%, 70.3%, and 44.3%, respectively. Additionally, the general and administrative expense ratios are anticipated to be 3.8%, 3.5%, and 3.4% for each corresponding year.
